Analysing adherence to guidelines for time-lapse imaging information on UK fertility clinic websites

References

• Abusief, M. E., Hornstein, M. D., & Jain, T, American Society for Reproductive Medicine, & Society for Assisted Reproductive Technology. (2007). Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines. Fertility and Sterility, 87(1), 88–92. https://doi.org/10.1016/j.fertnstert.2006.05.073
   PubMed Web of Science ®Google Scholar
• Armstrong, S., Arroll, N., Cree, L. M., Jordan, V., & Farquhar, C. (2015). Time-lapse systems for embryo incubation and assessment in assisted reproduction. The Cochrane Database of Systematic Reviews, 2015(2), CD011320. https://doi.org/10.1002/14651858.CD011320.pub2
   Google Scholar
• Armstrong, S., Bhide, P., Jordan, V., Pacey, A., Marjoribanks, J., & Farquhar, C. (2019). Time-lapse systems for embryo incubation and assessment in assisted reproduction. The Cochrane Database of Systematic Reviews, 5(5), CD011320. https://doi.org/10.1002/14651858.CD011320.pub4
   PubMedGoogle Scholar
• Carrick, M., Wilkinson, J., Polyakov, A., Kirkham, J., & Lensen, S. (2023). How do IVF patients interpret claims about fertility treatments? A randomised survey experiment. Human Fertility (Cambridge, England), 26(2), 347–354. https://doi.org/10.1080/14647273.2023.2191222
   PubMed Web of Science ®Google Scholar
• Galiano, V., Orvieto, R., Machtinger, R., Nahum, R., Garzia, E., Sulpizio, P., Marconi, A. M., & Seidman, D. (2021). Add-Ons" for assisted reproductive technology: Do patients get honest information from fertility clinics’ websites? Reproductive Sciences (Thousand Oaks, Calif.), 28(12), 3466–3472. https://doi.org/10.1007/s43032-021-00601-7
   PubMed Web of Science ®Google Scholar
• Hamper, J., & Perrotta, M. (2023). Watching embryos: Exploring the geographies of assisted reproduction through encounters with embryo imaging technologies. Social & Cultural Geography, 24(9), 1557–1575. https://doi.org/10.1080/14649365.2022.2073467
   Web of Science ®Google Scholar
• Harper, J., Jackson, E., Sermon, K., Aitken, R. J., Harbottle, S., Mocanu, E., Hardarson, T., Mathur, R., Viville, S., Vail, A., & Lundin, K. (2017). Adjuncts in the IVF laboratory: where is the evidence for 'add-on’ interventions? Human Reproduction (Oxford, England), 32(3), 485–491. https://doi.org/10.1093/humrep/dex004
   PubMed Web of Science ®Google Scholar
• Heneghan, C., Spencer, E. A., Bobrovitz, N., Collins, D. R., Nunan, D., Plüddemann, A., Gbinigie, O. A., Onakpoya, I., O'Sullivan, J., Rollinson, A., Tompson, A., Goldacre, B., & Mahtani, K. R. (2016). Lack of evidence for interventions offered in UK fertility centres. BMJ (Clinical Research ed.), 355, i6295. https://doi.org/10.1136/bmj.i6295
   PubMedGoogle Scholar
• Human Fertilisation and Embryology Authority (HFEA). (2019). Our national patient survey results. https://www.hfea.gov.uk/about-us/news-and-press-releases/2018-news-and-press-releases/our-national-patient-survey-results/
   Google Scholar
• Human Fertilisation and Embryology Authority (HFEA). (2021). State of the fertility sector 2020/21. https://www.hfea.gov.uk/about-us/publications/research-and-data/state-of-the-fertility-sector-2020-2021/
   Google Scholar
• Human Fertilisation and Embryology Authority (HFEA). (2022). National Patient Survey 2021. https://www.hfea.gov.uk/about-us/publications/research-and-data/national-patient-survey-2021
   Google Scholar
• Human Fertilisation and Embryology Authority (HFEA). (2023). Treatment add-ons with limited evidence. https://www.hfea.gov.uk/treatments/treatment-add-ons/
   Google Scholar
• Human Fertilisation and Embryology Authority (HFEA). (2024). HFEA dashboard. https://www.hfea.gov.uk/about-us/hfea-dashboard/
   Google Scholar
• Kieslinger, D. C., Vergouw, C. G., Ramos, L., Arends, B., Curfs, M. H. J. M., Slappendel, E., Kostelijk, E. H., Pieters, M. H. E. C., Consten, D., Verhoeven, M. O., Besselink, D. E., Broekmans, F., Cohlen, B. J., Smeenk, J. M. J., Mastenbroek, S., de Koning, C. H., van Kasteren, Y. M., Moll, E., van Disseldorp, J., … Lambalk, C. B. (2023). Clinical outcomes of uninterrupted embryo culture with or without time-lapse-based embryo selection versus interrupted standard culture (SelecTIMO): a three-armed, multicentre, double-blind, randomised controlled trial. Lancet (London, England), 401(10386), 1438–1446. https://doi.org/10.1016/S0140-6736(23)00168-X
   PubMed Web of Science ®Google Scholar
• Lensen, S., Armstrong, S., Vaughan, E., Caughey, L., Peate, M., Farquhar, C., Pacey, A., Balen, A. H., & Wainwright, E. (2023). It all depends on why it’s red": qualitative interviews exploring patient and professional views of a traffic light system for IVF add-ons. Reproduction and Fertility, 4(2), e220136. Advance online publication. https://doi.org/10.1530/RAF-22-0136
   PubMedGoogle Scholar
• Lensen, S., Chen, S., Goodman, L., Rombauts, L., Farquhar, C., & Hammarberg, K. (2021). IVF add-ons in Australia and New Zealand: A systematic assessment of IVF clinic websites. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 61(3), 430–438. https://doi.org/10.1111/ajo.13321
   PubMed Web of Science ®Google Scholar
• Lundin, K., Bentzen, J. G., Bozdag, G., Ebner, T., Harper, J., Le Clef, N., Moffett, A., Norcross, S., Polyzos, N. P., Rautakallio-Hokkanen, S., Sfontouris, I., Sermon, K., Vermeulen, N., & Pinborg, A, ESHRE Add-ons working group. (2023). Good practice recommendations on add-ons in reproductive medicine†. Human Reproduction (Oxford, England), 38(11), 2062–2104. https://doi.org/10.1093/humrep/dead184
   PubMed Web of Science ®Google Scholar
• Perrotta, M., & Geampana, A. (2020). The trouble with IVF and randomised control trials: Professional legitimation narratives on time-lapse imaging and evidence-informed care. Social Science & Medicine (1982), 258, 113115. https://doi.org/10.1016/j.socscimed.2020.113115
   PubMed Web of Science ®Google Scholar
• Perrotta, M., & Geampana, A. (2021). Enacting evidence-based medicine in fertility care: Tensions between commercialisation and knowledge standardisation. Sociology of Health and Illness, 43(9), 2015–2030. https://doi.org/10.1111/1467-9566.13381
   PubMed Web of Science ®Google Scholar
• Perrotta, M., & Hamper, J. (2021). The crafting of hope: Contextualising add-ons in the treatment trajectories of IVF patients. Social Science and Medicine (1982), 287, 114317. https://doi.org/10.1016/j.socscimed.2021.114317
   PubMed Web of Science ®Google Scholar
• Perrotta, M., & Hamper, J. (2023). Patient informed choice in the age of evidence-based medicine: IVF patients’ approaches to biomedical evidence and fertility treatment add-ons. Sociology of Health and Illness, 45(2), 225–241. https://doi.org/10.1111/1467-9566.13581
   PubMed Web of Science ®Google Scholar
• Sauerbrun-Cutler, M. T., Brown, E. C., Huber, W. J., Has, P., & Frishman, G. N. (2021). Society for assisted reproductive technology advertising guidelines: How are member clinics doing? Fertility and Sterility, 115(1), 104–109. https://doi.org/10.1016/j.fertnstert.2020.07.001
   PubMed Web of Science ®Google Scholar
• Spencer, E. A., Mahtani, K. R., Goldacre, B., & Heneghan, C. (2016). Claims for fertility interventions: A systematic assessment of statements on UK fertility centre websites. BMJ Open, 6(11), e013940. https://doi.org/10.1136/bmjopen-2016-013940
   PubMed Web of Science ®Google Scholar
• The Competition and Markets Authority (CMA). (2020). Self-funded IVF Research: Qualitative Research Report. https://assets.publishing.service.gov.uk/media/5fa01b30e90e070420702a1b/IVF_Research_Final_Report.pdf
   Google Scholar
• The Competition and Markets Authority (CMA). (2021a). Fertility treatment: A guide for Clinics. https://www.gov.uk/government/publications/fertility-treatment-a-guide-for-clinics
   Google Scholar
• The Competition and Markets Authority (CMA). (2021b). Fertility treatment: A guide to your consumer rights. https://www.gov.uk/government/publications/fertility-treatment-a-guide-to-your-consumer-rights
   Google Scholar
• The Competition and Markets Authority (CMA). (2022a). Patients’ experiences of buying fertility treatment: Qualitative Research Report. https://assets.publishing.service.gov.uk/media/632c2fefe90e073721b08402/Consumer_research_report_160922.pdf
   Google Scholar
• The Competition and Markets Authority (CMA). (2022b). Consumer law compliance review of fertility clinics: Findings report. https://assets.publishing.service.gov.uk/media/632d65af8fa8f51d1f83391a/A._Final_findings_report.pdf
   Google Scholar
• van de Wiel, L., Wilkinson, J., Athanasiou, P., & Harper, J. (2020). The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites. Reproductive Biomedicine Online, 41(5), 801–806. https://doi.org/10.1016/j.rbmo.2020.07.021
   PubMed Web of Science ®Google Scholar
• Wilkinson, J., & Stocking, K. (2021). Study design flaws and statistical challenges in evaluating fertility treatments. Reproduction and Fertility, 2(2), C9–C21. https://doi.org/10.1530/RAF-21-0015
   PubMedGoogle Scholar